Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study

INTRODUCTION: The EMBRACE study (Clinical Trials No. NCT02462759) evaluated nusinersen in infants/children with infantile‐ or later‐onset spinal muscular atrophy (SMA) who were ineligible for the ENDEAR and CHERISH studies. METHODS: Participants were randomized to intrathecal nusinersen (12‐mg scale...

Descripción completa

Detalles Bibliográficos
Autores principales: Acsadi, Gyula, Crawford, Thomas O., Müller‐Felber, Wolfgang, Shieh, Perry B., Richardson, Randal, Natarajan, Niranjana, Castro, Diana, Ramirez‐Schrempp, Daniela, Gambino, Giulia, Sun, Peng, Farwell, Wildon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248061/
https://www.ncbi.nlm.nih.gov/pubmed/33501671
http://dx.doi.org/10.1002/mus.27187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248061/
https://www.ncbi.nlm.nih.gov/pubmed/33501671
http://dx.doi.org/10.1002/mus.27187

Ejemplares similares